A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
INTERVENTION: Chinese traditional medicine group 1:Traditional Chinese medicine qingfei prescription treatment;Chinese traditional medicine group 2:Traditional Chinese medicine clear lung prescription and compound houttuynia mixture treatment;Control group:Conventional treatment; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: TCM symptom score;Antifebrile time;The time and rate of transition of new coronavirus to Yin; INCLUSION CRITERIA: 1) common type pneumonia patients with confirmed new coronavirus infection; 2) aged 18 to 75 years old; 3) voluntary signing of written informed consent.
Epistemonikos ID: e2a7a39943d8a706f6164adf0bd67050d48255f8
First added on: Apr 14, 2020